These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2565416)

  • 1. The reducing effects of tazifylline on histamine-induced bronchoconstriction in atopic asthmatics.
    Kiviranta K; Stenius-Aarniala B; Reuter C; Harlow B; Scott J
    Methods Find Exp Clin Pharmacol; 1989 Feb; 11(2):119-21. PubMed ID: 2565416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
    Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM
    Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiallergic effects of the new histamine H1-receptor antagonist tazifylline in healthy atopic and non-atopic subjects.
    Ring J; Galosi A; Harlow BJ; Reuter CA; Bieber T; Ruzicka T; Yee KF
    Arzneimittelforschung; 1988 Feb; 38(2):308-11. PubMed ID: 2897197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of fexofenadine--selective antagonist of histamine receptor (H1) on histamine-induced bronchoconstriction].
    Grzelewska-Rzymowska I; Kroczyńska-Bednarek J; Pietrzkowicz M
    Pol Merkur Lekarski; 2003 Jan; 14(79):43-6. PubMed ID: 12712828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
    Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of a new pharmacologic combination in the therapy of allergic respiratory diseases].
    Dolcetti A; Motta PE; Gaino T
    Clin Ter; 1969 Jan; 48(2):145-50. PubMed ID: 4396736
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of theophylline withdrawal on airway inflammation in asthma.
    Minoguchi K; Kohno Y; Oda N; Wada K; Miyamoto M; Yokoe T; Hashimoto T; Akabane T; Kobayashi H; Mita S; Kihara N; Adachi M
    Clin Exp Allergy; 1998 Aug; 28 Suppl 3():57-63. PubMed ID: 9756188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cromolyn modifies histamine bronchial reactivity in symptomatic seasonal asthma.
    Stafford WP; Mansfield LE; Yarbrough J
    Ann Allergy; 1984 Jun; 52(6):401-5. PubMed ID: 6428278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experiences with a new drug association with anti-asthmatic action].
    Martelli A
    Clin Ter; 1967 Jun; 41(6):529-44. PubMed ID: 4387419
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of once daily extended-release theophylline in decreasing the use of inhaled beta 2-agonists in stable, mild-to-moderate asthma patients.
    Edwards TB; Dockhorn RJ; Wagner DE; Fiddes RA; Grossman J; Menendez R; Southern DL; Cefali EA; Hassanein RS
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):409-16. PubMed ID: 7583862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of bronchial asthma].
    Iurenev PN; Frolova MK; Pashkova TL; Makarov AN
    Ter Arkh; 1974; 46(9):80-8. PubMed ID: 4155139
    [No Abstract]   [Full Text] [Related]  

  • 14. Histamine challenge in asthmatics at 07.00-12.00-17.00 and 22.00 h.
    Bundgaard A; Andersen KK
    Eur J Respir Dis Suppl; 1986; 143():14-7. PubMed ID: 3462008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the effects of inhaled magnesium on airway reactivity to histamine and adenosine monophosphate in asthmatic subjects.
    Hill J; Lewis S; Britton J
    Clin Exp Allergy; 1997 May; 27(5):546-51. PubMed ID: 9179429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chronobiology and chronopharmacology of allergy.
    Smolensky MH; Reinberg A; Queng JT
    Ann Allergy; 1981 Oct; 47(4):234-52. PubMed ID: 6118080
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of effect of loratadine on moderate to severe asthma.
    Ekström T; Osterman K; Zetterström O
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):287-9. PubMed ID: 7552933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of breathlessness during spontaneous asthma and histamine-induced bronchoconstriction.
    Boudreau D; Styhler A; Gray-Donald K; Martin JG
    Clin Invest Med; 1995 Feb; 18(1):25-32. PubMed ID: 7768063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up.
    Warner JO;
    J Allergy Clin Immunol; 2001 Dec; 108(6):929-37. PubMed ID: 11742270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with ipratropium and theophylline in asthma.
    Kreisman H; Cohen C; Ghezzo H; Vickerson F; Frank H; Wolkove N
    Ann Allergy; 1984 Feb; 52(2):90-3. PubMed ID: 6230034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.